173 related articles for article (PubMed ID: 26640580)
1. Malate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Exp Ther Med; 2015 Nov; 10(5):1959-1966. PubMed ID: 26640580
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.
Eleftheriadis T; Pissas G; Mavropoulos A; Liakopoulos V; Stefanidis I
Biomed Rep; 2017 Nov; 7(5):439-444. PubMed ID: 29181155
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.
Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):56-67. PubMed ID: 29512370
[TBL] [Abstract][Full Text] [Related]
5. A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration.
Ban HS; Xu X; Jang K; Kim I; Kim BK; Lee K; Won M
PLoS One; 2016; 11(9):e0162568. PubMed ID: 27611801
[TBL] [Abstract][Full Text] [Related]
6.
Kubohara Y; Fukunaga Y; Shigenaga A; Kikuchi H
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339168
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship study of chemical probes as hypoxia induced factor-1α/malate dehydrogenase 2 inhibitors.
Naik R; Won M; Ban HS; Bhattarai D; Xu X; Eo Y; Hong YS; Singh S; Choi Y; Ahn HC; Lee K
J Med Chem; 2014 Nov; 57(22):9522-38. PubMed ID: 25356789
[TBL] [Abstract][Full Text] [Related]
8. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line.
Lee K; Kang JE; Park SK; Jin Y; Chung KS; Kim HM; Lee K; Kang MR; Lee MK; Song KB; Yang EG; Lee JJ; Won M
Biochem Pharmacol; 2010 Oct; 80(7):982-9. PubMed ID: 20599784
[TBL] [Abstract][Full Text] [Related]
9. N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.
Shi W; Xu X; Yan F; Wang B; Zhao H; Chan A; Ren Z; Ma Y; Wang F; Yuan J
Oncol Lett; 2017 Dec; 14(6):6881-6887. PubMed ID: 29163707
[TBL] [Abstract][Full Text] [Related]
10. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
11. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells.
He G; Jiang Y; Zhang B; Wu G
Asia Pac J Clin Nutr; 2014; 23(1):174-80. PubMed ID: 24561986
[TBL] [Abstract][Full Text] [Related]
12. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas.
Vallée A; Guillevin R; Vallée JN
Rev Neurosci; 2018 Jan; 29(1):71-91. PubMed ID: 28822229
[TBL] [Abstract][Full Text] [Related]
13. Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism.
Naik R; Ban HS; Jang K; Kim I; Xu X; Harmalkar D; Shin SA; Kim M; Kim BK; Park J; Ku B; Oh S; Won M; Lee K
J Med Chem; 2017 Oct; 60(20):8631-8646. PubMed ID: 28991459
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1.
Kim BS; Lee K; Jung HJ; Bhattarai D; Kwon HJ
Biochem Biophys Res Commun; 2015 Feb; 458(1):14-20. PubMed ID: 25603055
[TBL] [Abstract][Full Text] [Related]
15. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
16. LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells.
Sato M; Hirose K; Kashiwakura I; Aoki M; Kawaguchi H; Hatayama Y; Akimoto H; Narita Y; Takai Y
Mol Med Rep; 2015 Sep; 12(3):3462-3468. PubMed ID: 26017562
[TBL] [Abstract][Full Text] [Related]
17. In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets.
Eleftheriadis T; Sounidaki M; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Mol Med Rep; 2016 Apr; 13(4):3370-6. PubMed ID: 26935268
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology.
Sutendra G; Michelakis ED
Front Oncol; 2013; 3():38. PubMed ID: 23471124
[TBL] [Abstract][Full Text] [Related]
19. Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1.
Zhang X; Liu P; Shang Y; Kerndl H; Kumstel S; Gong P; Vollmar B; Zechner D
J Cancer; 2020; 11(2):479-487. PubMed ID: 31897243
[TBL] [Abstract][Full Text] [Related]
20. Glycolytic, glutaminolytic and pentose-phosphate pathways in promyelocytic HL60 and DMSO-differentiated HL60 cells.
Ahmed N; Williams JF; Weidemann MJ
Biochem Mol Biol Int; 1993 Apr; 29(6):1055-67. PubMed ID: 8330014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
